Prevention & lipidsCohort study

Higher intakes of dietary dicarbonyl compounds are associated with lower risk of cardiovascular disease

Eur J Prev CardiolPublished

  • Case-cohort study
  • multi-national
  • prospective cohort

Authors' conclusion

Higher intakes of dietary MGO, GO, and 3-DG intake are associated with lower risk of non-fatal or fatal CVD.

Study context

Population
Cardiovascular disease (CVD)-free participants of the multi-national prospective EPIC cohort15,863 cases
Participants
32,873 participants
Exposure
Higher vs lower dietary dicarbonyl intake
Outcome
Incident non-fatal and fatal CVD (coronary heart disease (CHD) and/or stroke)

Main finding

As reported in the abstract

Non-fatal and fatal CVD, per 1 SD increase
HR
GOnon-fatal CVD
0.95(95% CI 0.92–0.98)
3-DGnon-fatal CVD
0.95(95% CI 0.92–0.98)
MGOfatal CVD
0.92(95% CI 0.87–0.97)
GOfatal CVD
0.91(CI 0.86–0.96)
3-DGfatal CVD
0.93(CI 0.86–0.99)

Per 1 SD increase, as printed

Observational data: associations, not effects.

Further findings

OutcomeHR
Non-fatal CHD, per 1 SD increase0.95 (CI 0.92–0.99)
Non-fatal stroke, per 1 SD increase — MGO0.93 (95% CI 0.90–0.96)
Non-fatal stroke, per 1 SD increase — GO0.90 (95% CI 0.86–0.95)
Non-fatal stroke, per 1 SD increase — 3-DG0.92 (95% CI 0.89–0.96)
Fatal CHD, per 1 SD increase — MGO0.94 (95% CI 0.88–0.99)
Fatal CHD, per 1 SD increase — GO0.92 (CI 0.86–0.98)
Fatal CHD, per 1 SD increase — 3-DG0.89 (CI 0.82–0.96)

Original publication

Higher intakes of dietary dicarbonyl compounds are associated with lower risk of cardiovascular disease. Eur J Prev Cardiol. Published 26 February 2025. doi:10.1093/eurjpc/zwaf060

Summarised from the published abstract; every number is checked against it